Williams Hart & Boundas, LLP has joined a team of leading plaintiffs' law firms to achieve a $7.25 billion settlement class action against Monsanto that would resolve thousands of existing and future claims involving Roundup exposure and non-Hodgkin lymphoma. The settlement, filed on February 17, 2026, by Williams Hart & Boundas, Waters Kraus Paul & Siegel, Motley Rice, Seeger Weiss, and the Holland Law Firm, in the City of St. Louis Circuit Court will establish a structured compensation framework for individuals diagnosed with NHL following exposure to Monsanto's glyphosate-based herbicide.
Over the past several years, juries nationwide have returned significant verdicts linking Roundup to non-Hodgkin lymphoma, while tens of thousands of claims remain pending in state and federal courts. According to the settlement, Monsanto will fund up to $7.25 billion to compensate a class that includes virtually all existing and certain future Roundup cancer claims. The agreement is designed to provide a structured and comprehensive resolution framework for individuals diagnosed with non-Hodgkin lymphoma following exposure to the herbicide.
"After years of pressing cases against Monsanto and in light of the fact that the U.S. Supreme Court has accepted an appeal to review the validity of these Round-Up claims, we are pleased to achieve a resolution that we believe is acceptable based on the current circumstances," said John Eddie Williams, Jr., Founding and Managing Partner of Williams Hart & Boundas, LLP. The timing of this settlement is particularly significant given the pending Supreme Court review, which could have affected the legal standing of thousands of claims.
Under the proposed settlement, eligible class members will have the right to opt out and pursue their claims individually if they choose. This massive settlement represents one of the largest product liability resolutions in recent history and provides a potential path to compensation for individuals who have developed non-Hodgkin lymphoma after using the widely available herbicide. The case is filed in St. Louis city court, where many similar claims have been consolidated.
The settlement's importance extends beyond the immediate financial compensation, as it establishes a formal recognition of the connection between Roundup exposure and non-Hodgkin lymphoma through a court-approved resolution process. This development comes after years of litigation and scientific debate about the safety of glyphosate-based products, which have been used extensively in agricultural, commercial, and residential settings worldwide. The structured framework aims to provide consistent compensation standards while potentially reducing the burden on court systems handling tens of thousands of individual claims.
For Texas businesses and industries, this settlement has significant implications for product liability standards and corporate responsibility. The involvement of Texas-based Williams Hart & Boundas, LLP in this landmark case demonstrates the state's growing influence in national legal matters affecting consumer safety and corporate accountability. The resolution may influence how Texas companies approach product safety testing and liability management, particularly in industries involving chemical products or agricultural inputs.
The economic impact of this settlement extends to multiple sectors in Texas, including agriculture, manufacturing, and legal services. As one of the largest agricultural states in the nation, Texas businesses that use or produce similar products may need to reassess their liability exposure and safety protocols. The structured compensation framework established by this settlement could serve as a model for future mass tort resolutions, potentially affecting how Texas courts handle complex product liability cases involving widespread consumer exposure.
